Shigehiro Uezono

604 total citations
22 papers, 442 citations indexed

About

Shigehiro Uezono is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Shigehiro Uezono has authored 22 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Hematology. Recurrent topics in Shigehiro Uezono's work include Renal Diseases and Glomerulopathies (6 papers), Vasculitis and related conditions (6 papers) and Dialysis and Renal Disease Management (3 papers). Shigehiro Uezono is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Vasculitis and related conditions (6 papers) and Dialysis and Renal Disease Management (3 papers). Shigehiro Uezono collaborates with scholars based in Japan and United States. Shigehiro Uezono's co-authors include Shouichi Fujimoto, Shuichi Hisanaga, Akira Ueda, Naoko Yokota‐Ikeda, Hiroyuki Komatsu, Hiroko Sonoda, S Kobayashi, Masahiro Ikeda, Yosuke Kanno and Kazuya Yoshinaga and has published in prestigious journals such as Nutrients, American Journal of Physiology-Renal Physiology and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Shigehiro Uezono

21 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigehiro Uezono Japan 11 193 165 156 54 52 22 442
Kathrin Schmidbauer Germany 12 202 1.0× 134 0.8× 139 0.9× 57 1.1× 46 0.9× 15 636
Fumiko Kodama Japan 13 110 0.6× 97 0.6× 227 1.5× 36 0.7× 28 0.5× 29 451
Lindi Jiang China 14 172 0.9× 185 1.1× 135 0.9× 27 0.5× 113 2.2× 22 638
Yi-Chun Xu-Dubois France 16 103 0.5× 189 1.1× 189 1.2× 48 0.9× 22 0.4× 28 631
Deyu Zheng China 15 405 2.1× 88 0.5× 141 0.9× 98 1.8× 100 1.9× 33 563
M Szmitkowski Poland 12 124 0.6× 89 0.5× 88 0.6× 18 0.3× 38 0.7× 34 630
Nurşen Keleş Türkiye 11 78 0.4× 112 0.7× 94 0.6× 126 2.3× 31 0.6× 33 473
Agnes Trautmann Germany 8 130 0.7× 168 1.0× 428 2.7× 11 0.2× 34 0.7× 10 581
Naqiang Lv China 12 262 1.4× 46 0.3× 69 0.4× 110 2.0× 98 1.9× 40 419
Rivka Ayalon United States 13 200 1.0× 160 1.0× 418 2.7× 61 1.1× 90 1.7× 17 641

Countries citing papers authored by Shigehiro Uezono

Since Specialization
Citations

This map shows the geographic impact of Shigehiro Uezono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigehiro Uezono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigehiro Uezono more than expected).

Fields of papers citing papers by Shigehiro Uezono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigehiro Uezono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigehiro Uezono. The network helps show where Shigehiro Uezono may publish in the future.

Co-authorship network of co-authors of Shigehiro Uezono

This figure shows the co-authorship network connecting the top 25 collaborators of Shigehiro Uezono. A scholar is included among the top collaborators of Shigehiro Uezono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigehiro Uezono. Shigehiro Uezono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uezono, Shigehiro, et al.. (2021). Impact of polypharmacy on all-cause mortality and hospitalization in incident hemodialysis patients: a cohort study. Clinical and Experimental Nephrology. 25(11). 1215–1223. 6 indexed citations
2.
Uezono, Shigehiro, et al.. (2021). Takotsubo cardiomyopathy after vaccination for coronavirus disease 2019 in a patient on maintenance hemodialysis. CEN Case Reports. 11(2). 220–224. 16 indexed citations
3.
Komatsu, Hiroyuki, et al.. (2020). Association between Serum Zinc Levels and Clinical Index or the Body Composition in Incident Hemodialysis Patients. Nutrients. 12(10). 3187–3187. 10 indexed citations
5.
Sato, Yuji, Hiroyuki Komatsu, Shigehiro Uezono, et al.. (2016). Risk of Cerebral Infarction in Japanese Hemodialysis Patients: Miyazaki Dialysis Cohort Study (MID study). Kidney & Blood Pressure Research. 41(4). 471–478. 10 indexed citations
6.
Sato, Yuji, Hiroyuki Komatsu, Masao Kikuchi, et al.. (2015). Glycaemic control is a predictor of infection‐related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study). Nephrology. 21(3). 236–240. 3 indexed citations
7.
Kawano, Noriaki, Naoko Yokota‐Ikeda, Shuro Yoshida, et al.. (2013). Therapeutic Modality of 11 Patients with TTP in a Single Institution in Miyazaki from 2000 to 2011. Internal Medicine. 52(17). 1883–1891. 9 indexed citations
9.
Ono, Nobuyuki, et al.. (2013). Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature. Modern Rheumatology. 23(3). 554–563. 6 indexed citations
10.
Kawano, Noriaki, Shuro Yoshida, Kiyoshi Yamashita, et al.. (2013). Clinical Characteristics and Outcomes of 11 Patients with Pure Red Cell Aplasia at a Single Institution Over a 13-Year Period. Internal Medicine. 52(18). 2025–2030. 3 indexed citations
11.
Ono, Nobuyuki, et al.. (2012). Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature. Modern Rheumatology. 23(3). 554–563. 8 indexed citations
12.
Kawano, Noriaki, Naoko Yokota‐Ikeda, Sayaka Kawano, et al.. (2011). Successful treatment of non-Hodgkin's lymphoma with rituximab and dose-adjusted CHOP therapy in a patient with concomitant end-stage renal disease requiring haemodialysis. Clinical Kidney Journal. 4(3). 186–189. 3 indexed citations
13.
Ochiai, Hidenobu, et al.. (2010). Factors affecting outcome of intracerebral hemorrhage in patients undergoing chronic hemodialysis. Renal Failure. 32(8). 923–927. 10 indexed citations
15.
Sonoda, Hiroko, Naoko Yokota‐Ikeda, Yosuke Kanno, et al.. (2009). Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury. American Journal of Physiology-Renal Physiology. 297(4). F1006–F1016. 121 indexed citations
16.
Uezono, Shigehiro, Yuji Sato, Seiichiro Hara, et al.. (2007). Outcome of ANCA-Associated Primary Renal Vasculitis in Miyazaki Prefecture. Internal Medicine. 46(12). 815–822. 16 indexed citations
17.
Fujimoto, Shouichi, Shigehiro Uezono, Shuichi Hisanaga, et al.. (2006). Incidence of ANCA-Associated Primary Renal Vasculitis in the Miyazaki Prefecture. Clinical Journal of the American Society of Nephrology. 1(5). 1016–1022. 81 indexed citations
18.
Uezono, Shigehiro, Seiichiro Hara, Yuji Sato, et al.. (2006). Renal Biopsy in Elderly Patients: A Clinicopathological Analysis. Renal Failure. 28(7). 549–555. 35 indexed citations
19.
Kinoshita, Hiroshi, Shouichi Fujimoto, Kazuo Kitamura, et al.. (2000). Increased Plasma Levels of Mature Adrenomedullin in Chronic Glomerulonephritis. ˜The œNephron journals/Nephron journals. 86(3). 333–338. 16 indexed citations
20.
Tsuruda, Toshihiro, Shigehiro Uezono, Johji Kato, et al.. (1996). Extramedullary Plasmacytoma of the Jejunum.. Internal Medicine. 35(5). 422–426. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026